학술논문
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
Document Type
Article
Author
Source
In Annals of Oncology May 2020 31(5):609-618
Subject
Language
ISSN
0923-7534